TROW — T. Rowe Price Group, Inc.

Street sentiment is cautious: the structured FMP consensus is Hold (8 buys, 24 holds, 6 sells), while the live research brief paints a more bearish 0-buy/12-13-hold/4-7-sell picture. Either way, the average price target of $114.20 is barely above the $112.36 price, so the market is not pricing in meaningful upside or catastrophe.

Revenue has drifted up from ~$1.67B in Q3 2023 to $1.91B in Q2 2026, and Q2 2026 revenue was up 10.7% YoY with EPS of $2.88 versus $2.24 a year earlier. But the trend is lumpy: operating margin was 28.3% in Q2 2026 versus 34.6% in Q1 2026, and Q4 margins are consistently depressed by compensation seasonality (24.4% in Q4 2025). The top-line growth is largely market beta, not organic asset gathering—Q2 2026 still saw $6.5B of net client outflows. Q4 negative free cash flow is a seasonal artifact, but the active-equity outflow problem is structural.

Cheap versus its own history, but not deeply cheap on forward earnings. As of 2026-08-27, TTM P/E was 11.26x versus the 5-year average of 13.65x, P/S was 3.17x versus 4.01x, and PEG was 0.99. The dividend yield of 4.73% is supportive. However, consensus forward EPS is $10.19, below TTM EPS of $10.38, and the effective fee rate keeps sliding (38.1 bps in Q2 2026 versus 38.4 bps in Q1). The de-rating is logical for a high-quality, flat-earnings cash generator.

At $112.36 and consensus forward EPS of $10.19, the forward P/E is roughly 11.0x—essentially a no-growth multiple. The stock is not pricing in aggressive growth; it is pricing in stable dividends, buybacks, and flat earnings. If outflows stabilize and the F/m/ETF buildout starts to work, the multiple could re-rate toward 12-13x. If active equity outflows accelerate, today's cheap multiple becomes a value trap as EPS estimates get revised down.

As of 2026-08-27, RSI was 47.28, price was -0.18% versus the 20-day SMA, -1.5% versus the 50-day SMA, and +8.67% versus the 200-day SMA. That is a range-bound, neutral momentum profile—not overbought, not oversold, and still above the long-term trend. There is no urgent technical entry signal; a better risk/reward spot would be closer to the 50-day/200-day support or on a confirmed breakout above the $122 52-week high.

• Passive investing and fee compression remain secular headwinds; TROW's effective fee rate slipped to 38.1 bps in Q2 2026 from 38.4 bps in Q1.
• Rate normalization is shifting client demand toward fixed income, multi-asset, and private credit—areas TROW is trying to scale via Oak Hill and F/m.
• Equity market levels drive AUM and fee revenue; record $1.89T AUM is mostly beta, so a sustained market drawdown would hit both revenue and EPS.
• Cost discipline is the main near-term margin lever, with 2026 adjusted operating expense growth guided at 4-7%.
• The regulatory and competitive push toward ETFs, SMAs, and alternatives requires continuous product innovation and integration execution.

• Monthly AUM reports (second week of each month) provide a short-term read on flows and market beta.
• Q3 2026 earnings, tentatively late October 2026, will show whether operating margins and organic flows are stabilizing.
• Closing and integration of F/m Investments to expand fixed income ETF and SMA capabilities.
• Further capital returns: TROW bought back $497M year-to-date and has a fortress balance sheet, so dividend increases or buyback acceleration would support the stock.

• Persistent active equity outflows: Q2 2026 had $13.5B of equity outflows, partially offset by fixed income/multi-asset/alternatives inflows, for a net -$6.5B.
• Fee-rate compression and mix shift into lower-fee vehicles reduce revenue growth even when AUM is flat.
• A market correction would cut AUM, fee revenue, and EPS given the 1.48 beta.
• Forward EPS is flat: consensus next-FY EPS of $10.19 is below TTM EPS of $10.38, leaving little earnings cushion.
• Execution/integration risk across private markets, digital assets, and the new ETF/SMA initiatives.

TROW is a financially strong, debt-free cash machine trading below its historical multiple, but the active-equity franchise continues to leak assets and forward EPS is flat. That makes it an income-oriented hold rather than a clear growth buy; I lean cautiously bearish because the low multiple is justified until flows and fee rates stabilize.

Calculated as 11.5x consensus forward EPS of $10.19 = $117.20. That multiple is about 16% below TROW's 5-year average P/E of 13.65x to reflect flat forward earnings, active outflows, and fee compression, and it cross-checks with the current P/B of ~2.2x and a dividend yield near 4.7%.